Free Trial

Sartorius Aktiengesellschaft (OTCMKTS:SARTF) Trading Up 0.6% - What's Next?

Sartorius Aktiengesellschaft logo with Medical background

Sartorius Aktiengesellschaft (OTCMKTS:SARTF - Get Free Report) shot up 0.6% during trading on Monday . The stock traded as high as $185.22 and last traded at $185.17. 89 shares traded hands during mid-day trading, a decline of 38% from the average session volume of 144 shares. The stock had previously closed at $184.00.

Analyst Ratings Changes

Several equities research analysts recently weighed in on SARTF shares. Wolfe Research upgraded shares of Sartorius Aktiengesellschaft to a "strong-buy" rating in a research note on Thursday, November 14th. Guggenheim raised Sartorius Aktiengesellschaft to a "strong-buy" rating in a report on Thursday, December 19th.

View Our Latest Analysis on Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft Price Performance

The company has a debt-to-equity ratio of 1.17, a current ratio of 2.02 and a quick ratio of 1.13. The stock has a market capitalization of $6.34 billion, a price-to-earnings ratio of 141.35 and a beta of 1.01. The company has a 50-day simple moving average of $192.63 and a two-hundred day simple moving average of $202.01.

Sartorius Aktiengesellschaft (OTCMKTS:SARTF - Get Free Report) last released its quarterly earnings data on Thursday, October 17th. The company reported $0.96 earnings per share for the quarter. The business had revenue of $872.19 million for the quarter. Sartorius Aktiengesellschaft had a net margin of 2.50% and a return on equity of 7.69%.

About Sartorius Aktiengesellschaft

(Get Free Report)

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Sartorius Aktiengesellschaft Right Now?

Before you consider Sartorius Aktiengesellschaft, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sartorius Aktiengesellschaft wasn't on the list.

While Sartorius Aktiengesellschaft currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Nuclear energy is making a resurgence! Watch to find out which seven nuclear energy stocks could deliver long-term gains in the transition to cleaner energy.

Related Videos

Pelosi Bets Big on AI: Her Top 5 Stock Picks
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines